Posted on 30/07/03
Biovail shares hit on poor results
Investors pounded Biovail Corp. yesterday, sending the stock price down nearly 10 per cent as several analysts downgraded the stock after the drug maker posted what they called disappointing second-quarter results.
The full text of this article has 674 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
